Skip to main content
TLRYTilray Brands, Inc.Sell5.0·$4.63+4.51%
Open full analysis

Tilray Brands, Inc. (TLRY) Stock Analysis

Inst Constrain edge

SellVALUE-TRAP 3/5Moderate Confidence

Healthcare · Drug Manufacturers - Specialty & Generic

Sell if holding. Engine safety override at $4.63: Quality below floor (2.3 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.0/10 and A.R:R 8.5:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 15%; Below-average business quality; Negative price momentum.

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four... Read more

QualityF-score4 / 9FCF yield-5.45%
Stop $4.30Target $8.74(analyst − 13%)A.R:R 8.5:1
Analyst target$10.04+116.9%9 analysts
$8.74our TP
$4.63price
$10.04mean
$24

Sell if holding. Engine safety override at $4.63: Quality below floor (2.3 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.0/10 and A.R:R 8.5:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 15%; Below-average business quality; Negative price momentum. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.0/10, moderate confidence.

Passes 6/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, earnings proximity 24d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: speculative.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-07-05

Recent Developments — Tilray Brands, Inc.

Latest news

Generated 2026-07-05T09:50:26Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Tue, Jul 28, 202624d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Quality below floor (2.3 < 4.0)
Value-trap signals (3/5): Margin compression (op margin -39.8%), Material insider selling (3 sells, 0.04% of cap), Negative free cash flow

Key Metrics

P/E (TTM)
P/E (Fwd)17.0
Mkt Cap$570M
EV/EBITDA111.8
Profit Mgn-156.7%
ROE-63.2%
Rev Growth-7.8%
Beta1.90
DividendNone
Rating analysts17

Quality Signals

Piotroski F4/9

Options Flow

P/C0.57bullish
IV98%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

4 floor-breakers·1 ceiling hit

Unprofitable operations — net margin -156.7%. Quality floor flags this regardless of sector context.static

Roe
0.0
Roa
0.0
Operating Margin
0.0
Fcf Quality
0.0
Gross Margin
1.5
Moat
3.2
Piotroski F
4.4
Current Ratio
9.4
Cash-burning: FCF -4% of revenueNo competitive moatQuality concerns

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
0.1
Growth Rank
1.4
Value Rank
8.6

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Earnings History
0.0
Surprise Avg
0.0
Erm
5.0
Earnings Timing
5.0
News Activity
5.0

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Obv
1.0
Ma Position
1.0
Rsi
3.5
Macd
6.3
Volume
6.4
Volume distribution (falling OBV)Below 200-MA, MA slope -9.0%/30d — confirmed downtrend
GatesMomentum 3.6<4.5Death cross (50MA < 200MA)A.R:R 8.5 ≥ 1.5Insider activity: OKNo SEC red flagsEARNINGS PROXIMITY 24d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Speculative
RSI
31 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $4.28Resistance $5.48

Price Targets

$4
$9
A.Upside+88.8%
A.R:R8.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (2.3 < 4.0)
! Value-trap signals (3/5): Margin compression (op margin -39.8%), Material insider selling (3 sells, 0.04% of cap), Negative free cash flow
! momentum at 3.6 (below the engine's 4.5 threshold)

Earnings

M
M
M
M
0/4 beats
Next Earnings2026-07-28 (24d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is TLRY stock a buy right now?

Sell if holding. Engine safety override at $4.63: Quality below floor (2.3 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.0/10 and A.R:R 8.5:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 15%; Below-average business quality; Negative price momentum. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $4.30. Score 5.0/10, moderate confidence.

What is the TLRY stock price target?

Take-profit target: $8.74 (+89.2% upside). Prior stop was $4.30. Stop-loss: $4.30.

What are the risks of investing in TLRY?

Quality below floor (2.3 < 4.0); Value-trap signals (3/5): Margin compression (op margin -39.8%), Material insider selling (3 sells, 0.04% of cap), Negative free cash flow.

Is TLRY overvalued or undervalued?

Tilray Brands, Inc. trades at a P/E of N/A (forward 17.0). TrendMatrix value score: 9.2/10. Verdict: Sell.

What do analysts say about TLRY?

17 analysts cover TLRY with a consensus score of 3.6/5. Average price target: $10.

What does Tilray Brands, Inc. do?Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and...

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Cruisies, Atwater Brewery, Hiball Energy, Liquid Love, Hop Valley Brewing, Redhook Brewery, Revolver Brewing, Square Mile Cider, Mock One, Widmer Brothers Brewing, Runner's High Brewing Company, SweetWater Brewing Company, Terrapin Beer Co., Happy Flower, Fizzy Jane's, Herb & Bloom, 420 Fizz, and Fresh Hemp Foods brands. The company sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Related stocks: IRWD (Ironwood Pharmaceuticals, Inc.) · ANIP (ANI Pharmaceuticals, Inc.) · INDV (Indivior Pharmaceuticals, Inc.) · BHC (Bausch Health Companies Inc.) · COLL (Collegium Pharmaceutical, Inc.)
Home Stocks TLRY

Latest news

Latest News

Benzinga6d agoMerger Acquisition